AbbVie
ABBV
#36
Rank
โ‚น36.080 T
Marketcap
โ‚น20,422
Share price
-2.14%
Change (1 day)
28.25%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): โ‚น578.09 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น61.16 Billion. , an increase over its 2024 earnings that were of โ‚น350.53 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น622.29 B77.53%
2024 โ‚น350.53 B-40.54%
2023 โ‚น589.56 B-53.62%
2022 โ‚น1.271 T3.76%
2021 โ‚น1.225 T282.25%
2020 โ‚น320.53 B-59.67%
2019 โ‚น794.82 B62.13%
2018 โ‚น490.23 B-32.74%
2017 โ‚น728.88 B-1.99%
2016 โ‚น743.69 B18.65%
2015 โ‚น626.82 B180.5%
2014 โ‚น223.46 B-55.57%
2013 โ‚น502.96 B-6.86%
2012 โ‚น540.03 B56.05%
2011 โ‚น346.05 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น999.04 B 60.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.936 T 371.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น857.17 B 37.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น153.09 B-75.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น924.15 B 48.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น905.28 B 45.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.383 T 122.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น944.37 B 51.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น75.35 B-87.89%๐Ÿ‡บ๐Ÿ‡ธ USA